Colossal Biosciences announced a major breakthrough in its dodo revival effort, moving the iconic bird from the pages of history toward a possible future in the wild. The company’s latest milestone—successfully editing a closely related pigeon genome to express key dodo traits—demonstrates that the dodo revival is no longer a distant dream but a tangible scientific pursuit. This development, revealed in October 2026, builds on years of genome sequencing, synthetic biology, and collaborative conservation work. Why the Dodo Matters in 2026 The dodo, once endemic to Mauritius, became a symbol of human‑induced extinction after disappearing in the late 17th century. While the bird’s story is well‑known, its ecological role remains a subject of research. Restoring the dodo could help re‑balance island ecosystems, offering insights into how re‑introduced megafauna affect seed dispersal, forest regeneration, and predator‑prey dynamics. In 2026, these ecological questions are more urgent than ever as climate change reshapes habitats worldwide. Colossal’s Roadmap: From DNA to Living Bird Since its founding in 2021, Colossal has pursued a step‑by‑step roadmap for de‑extinction. The first phase involved sequencing the dodo’s genome from museum specimens, a task completed in 2023. Phase two focused on identifying functional genes responsible for flightlessness, plumage, and beak morphology. In 2025, the team successfully edited the genome of the Nicobar pigeon—a close relative—to carry several dodo‑specific genes. The latest achievement, announced this month, is the creation of viable embryos that develop key dodo characteristics, marking a critical advance toward the dodo revival goal. Technical Challenges and How They’re Being Overcome Reviving an extinct species is fraught with technical hurdles. One major challenge is the degradation of ancient DNA, which can introduce errors during sequencing. Colossal addressed this by employing ultra‑high‑fidelity polymerases and cross‑referencing multiple museum samples to reconstruct a consensus genome. Another obstacle is ensuring that edited embryos can develop normally. The company partnered with leading avian embryologists to refine incubation protocols, using surrogate species that share similar developmental timelines. Ethical considerations also play a central role. Colossal has established an independent advisory board comprising ethicists, ecologists, and indigenous representatives to evaluate each step. The board’s guidance ensures that the dodo revival proceeds responsibly, with a focus on long‑term ecological benefit rather than novelty. Scientific Methodology Explained The core methodology combines three pillars: high‑resolution paleogenomics, CRISPR‑based multiplex editing, and synthetic embryo culture. First, paleogenomic reconstruction uses overlapping fragments from dozens of specimens to fill gaps, producing a near‑complete reference. Second, multiplex CRISPR enables simultaneous insertion of dozens of dodo‑specific alleles into the pigeon genome, reducing off‑target risk through paired‑nickase strategies. Third, synthetic embryo culture leverages a bioreactor that mimics the avian yolk environment, allowing embryos to develop to the gastrulation stage before transfer to a surrogate. Example: Gene Editing Workflow Example 1 – Inserting the Flightlessness Gene Identify the FOXP2 variant linked to reduced wing musculature in the dodo genome. Design a pair of guide RNAs flanking the target locus in the Nicobar pigeon genome. Deliver CRISPR‑Cas9 ribonucleoprotein complexes via electroporation into fertilized pigeon zygotes. Screen edited embryos using droplet‑digital PCR to confirm precise insertion. Transfer successfully edited embryos to surrogate pigeon incubators for further development. This workflow was repeated for plumage and beak morphology genes, resulting in embryos that display a combination of dodo‑like traits. Implications for Conservation and Biodiversity If successful, the dodo revival could reshape conservation strategies worldwide. Traditional approaches often focus on protecting existing species, but de‑extinction offers a complementary pathway to restore lost ecological functions. For island nations like Mauritius, reintroducing the dodo could enhance forest health, promote native plant regeneration, and provide a flagship species for eco‑tourism. Moreover, the technologies honed during this project—precise genome editing, synthetic embryo development, and cross‑species surrogacy—are transferable to other endangered or extinct taxa. Critics caution that resources might be diverted from pressing conservation needs. However, Colossal argues that the research infrastructure and public interest generated by the dodo revival can cataly‑cally boost funding for broader biodiversity initiatives. In 2026, several governments, including the United Kingdom and Canada, have expressed interest in supporting de‑extinction research as part of their climate‑resilience plans. Regulatory Framework and Compliance All experimental phases comply with the International Convention on Biological Diversity (CBD) and the Convention on International Trade in Endangered Species (CITES). Colossal has filed detailed risk‑assessment dossiers with the Mauritian Ministry of Environment, outlining containment protocols, genetic monitoring plans, and post‑release ecological surveys. The company also adheres to the U.S. National Institutes of Health’s Recombinant DNA Advisory Committee (RAC) guidelines for gene‑editing work. Potential Risks and Mitigation Strategies Key risks include unintended ecological interactions, disease transmission, and genetic drift in small founder populations. Mitigation includes: Conducting closed‑environment trials for at least two generations before any field release. Implementing a bio‑containment protocol that uses sterilized feed and quarantine enclosures. Performing whole‑genome sequencing of each hatchling to monitor off‑target mutations. Establishing a monitoring consortium with local universities to track ecosystem impacts in real time. Global Partnerships and Funding Landscape The dodo revival project is a multinational effort. Colossal collaborates with universities in the United States, the United Kingdom, and Australia, as well as conservation NGOs in South Africa and Kenya. Funding comes from a mix of venture capital, government grants, and philanthropic foundations focused on innovative conservation. In early 2026, the company secured a $50 million round led by impact investors, earmarked for scaling up embryo incubation facilities and conducting controlled release trials. These partnerships also ensure that any future reintroduction aligns with local regulations and cultural values. For instance, Mauritian authorities have been consulted on habitat suitability, and community outreach programs are underway to educate residents about the potential benefits and risks of the dodo revival. Looking Ahead: Timeline Toward a Living Dodo Colossal outlines a tentative timeline extending into 2027 and beyond. By mid‑2027, the team aims to produce a small cohort of hatchlings that exhibit core dodo traits. Following rigorous health and behavioral assessments, the next phase will involve semi‑controlled environments on Mauritius to monitor adaptation and ecological impact. Full wild release is projected for the early 2030s, contingent on successful trials and regulatory approval. Throughout this process, transparency remains a priority. The company plans to release quarterly updates, open‑source portions of its genome editing protocols, and host public webinars to keep stakeholders informed about progress and challenges. FAQ What is the current status of the dodo revival? As of October 2026, Colossal has produced viable embryos with key dodo genetic traits, marking the first tangible step toward a living dodo. Will the revived dodo be genetically identical to the original? The revived bird will carry the majority of the dodo genome, but some genetic material will be derived from the surrogate species to ensure viability. How will the dodo be reintroduced into the wild? Reintroduction will occur in phased trials on Mauritius, starting with secure, monitored enclosures before any full release. What safeguards are in place to prevent ecological harm? Colossal follows a strict containment protocol, conducts multi‑generational health screenings, and works with local ecologists to model potential ecosystem impacts before any release. Can the techniques used for the dodo be applied to other extinct species? Yes, the same CRISPR‑multiplex and synthetic embryo platforms are being adapted for projects targeting the passenger pigeon and the thylacine. For more details, see the original announcement on Fast Company. Additional background on de‑extinction can be found in our de‑extinction overview article. Related reading Palantir Police Contract Settlement Signals New Era for Tech–law Enforcement Partnerships US Electric Vehicle Sales Revive After Three Quarters of Growth Lagos Gives MTN, Airtor, Others 30 Days to Verify Betting Licences Related posts: How a Fruit Fly’s Brain Sparked the Wildest Story Ideas of 2026 African Tech Unicorns Eye the Public Markets in 2026 EU Moves to Limit Social Media for Under‑15s, Raising Global Debate The Right to Repair Surge: Consumers Demand Control over Their Devices in 2026 Post navigation Palantir Police Contract Settlement Signals New Era for Tech–law Enforcement Partnerships
